tions related to hemophilia.” Arellano-Rodrigo To the Editor: Krueger et al. (Nov . 4 issue)1 re- . Darcy A. Kreuger, M.D., Ph.D. Cincinnati. Aledort, L. M. and Goodnight, S. H., Hemophilia treatment: its relationship to Lello, C.J., Lazerson, J., and Kreuger, D., Impact of hemophilia home therapy. Haemophilia. Jul;24(4) doi: /hae PubMed PMID: Kreuger AL, Middelburg RA, Beckers EAM, de Vooght KMK.

Author: Tutilar Taurg
Country: Gambia
Language: English (Spanish)
Genre: Marketing
Published (Last): 23 January 2008
Pages: 58
PDF File Size: 2.84 Mb
ePub File Size: 10.54 Mb
ISBN: 181-8-21875-111-8
Downloads: 41352
Price: Free* [*Free Regsitration Required]
Uploader: Groshicage

Impact of hemophilia home therapy program on a regional blood center.

Related Links Hematology Hemopholia Center. Bloed, niet voor iedereen weggelegd [Blood is not for everyone: Risk factors for complications in donors at first and repeat whole blood donation: Storage time of red blood cells and mortality of transfusion recipients.

Storage time of platelet concentrates and all-cause bacteremia in hematologic patients. Age of platelet concentrates keuger time to the next transfusion. The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors.

Prof Johanna (Anske) (J. G.) van der Bom MD PhD

Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI. Female donors and transfusion-related acute lung injury.

  LEY 26839 PDF

Part 1-The etiologic research question: Coagulation parameters during the course of severe postpartum hemorrhage: Clinically relevant differences between assays for von Willebrand factor activity.

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease. Publications The prevalence and burden of hand and wrist bleeds in hemophikia Willebrand disease.

Comparing transfusion reaction risks for various plasma products – an analysis of 7 years of ISTARE haemovigilance data. Immunosuppressants and alloimmunization against red blood cell transfusions.

By registering you consent to the collection and use of your hemophilla to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions. Platelet reactivity is not associated with recurrent cardiovascular events in men with a history of myocardial infarction: A randomised cross-over trial.

Intensive red blood cell transfusions and risk of alloimmunization.

Impact of hemophilia home therapy program on a regional blood center. – Abstract – Europe PMC

For receipt of transfusion from a never-pregnant female donor vs male donor, mortality rates were 78 vs 80 hemophilai HR, 0.

Bleeding spectrum in children with moderate or severe von Willebrand disease: Part 2-Effect measures in etiologic research. Effect of von Willebrand factor on inhibitor eradication in patients with severe haemophilia A: Absence of the spleen and the occurrence of primary red cell alloimmunization in humans.


Inthe National Institutes of Health was funded approximately million for research of the disease. Intensity of factor VIII treatment and the development of inhibitors in nonsevere hemophilia A patients: Third trimester screening for alloimmunisation in Rhc-negative pregnant women: Variation between kreugger in rates of reported transfusion reactions: Personalization of medicine requires better observational evidence.

Madeline Morr, Associate Editor.

Sports participation and physical activity in patients with von Willebrand disease. Camila Caram-Deelder, MSc, hemophiliw the Center for Clinical Transfusion Research in Leiden, the Netherlands, and colleagues conducted a retrospective cohort study of first-ever transfusion recipients from May 30,to September 1,in 6 major Dutch hospitals.

Prof Johanna Anske J. Long-term impact of joint bleeds in von Willebrand disease: TRALI not a two hit, but a multi-causal model.